MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 995 |
Device Problem
Degraded (1153)
|
Patient Problems
Atrial Fibrillation (1729); Cardiac Arrest (1762); Stroke/CVA (1770); Non specific EKG/ECG Changes (1817); Hemorrhage/Bleeding (1888); Unspecified Infection (1930); Sepsis (2067)
|
Event Date 05/04/2019 |
Event Type
Injury
|
Event Description
|
Medtronic received information from a literature article regarding the influence of an aortic root abscess on perioperative outcomes and long-term survival in patients with active endocarditis treated with surgical aortic valve or root replacement.All data was collected from a single center between 1996 and october 2019.Of the 336 patients with active endocarditis included in the study population (predominantly male, median age 55 years), 176 underwent aortic root replacement with a medtronic freestyle bioprosthesis (root abscess = 119, no root abscess = 57).No unique device identifier numbers were provided.Among all 336 patients, the 10-year survival rates were 41% and 43% for patients with root abscess and no root abscess, respectively.No statement was made suggesting a causal or contributory relationship between freestyle and any of the deaths.Among all 336 patients, post-operative non-death adverse events included: red blood cell transfusion (1 to 7 units); reoperation for bleeding; sternal dehiscence; sepsis; stroke; cardiac arrest; permanent pacemaker or implantable cardioverter defibrillator implantation; atrial fibrillation; and reoperation for structural valve deterioration or reinfection.Freestyle may have been associated with these adverse events.No additional adverse patient effects or product performance issues were reported.
|
|
Manufacturer Narrative
|
Citation: yang b, et al.Root abscess in the setting of infectious endocarditis: short- and long-term outcomes.J thorac cardiovasc surg.2021 oct;162(4):1049-1059.E1.Doi: 10.1016/j.Jtcvs.2019.12.140.Epub 2020 apr 13.Read at the 99th annual meeting of the american association for thoracic surgery, toronto, ontario, canada, may 4-7, 2019.Earliest date of presentation used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product, no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|